Harvard Bioscience, Inc. (HBIO)
USD 2.03
(-6.45%)
USD 2.03
(-6.45%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 112.25 Million | 113.33 Million | 118.9 Million | 102.1 Million | 116.17 Million | 120.77 Million |
| Cost of Revenue | 51.38 Million | 52.51 Million | 51.25 Million | 44.05 Million | 51.85 Million | 57.59 Million |
| Gross Profit | 60.86 Million | 60.81 Million | 67.65 Million | 58.04 Million | 64.32 Million | 63.18 Million |
| Operating Expenses | 58.58 Million | 67.98 Million | 65.58 Million | 57.82 Million | 62.48 Million | 62.19 Million |
| Selling, General and Administrative Expenses | 46.81 Million | 49.53 Million | 48.94 Million | 43.42 Million | 46.02 Million | 45.82 Million |
| Research and Development Expenses | 11.76 Million | 12.32 Million | 10.79 Million | 8.68 Million | 10.71 Million | 10.98 Million |
| Other Expenses | 6.12 Million | 6.12 Million | 5.84 Million | 5.71 Million | 5.74 Million | -4.28 Million |
| Cost and Expenses | 110.35 Million | 120.5 Million | 116.83 Million | 101.87 Million | 114.33 Million | 119.79 Million |
| Operating Income | 1.89 Million | -7.16 Million | 1.4 Million | -585 Thousand | 1.47 Million | 984 Thousand |
| Interest Expense | 3.59 Million | 2.24 Million | 1.54 Million | 4.83 Million | 5.41 Million | 5.36 Million |
| Income Tax Expense | 859 Thousand | 337 Thousand | 148 Thousand | 518 Thousand | -815 Thousand | -3.67 Million |
| Earnings before Tax | -2.55 Million | -9.17 Million | -140 Thousand | -7.29 Million | -5.5 Million | -8.51 Million |
| Net Income | -3.41 Million | -9.51 Million | -288 Thousand | -7.81 Million | -4.68 Million | -3.46 Million |
| Earnings Per Share Basic | -0.08 | -0.23 | -0.01 | -0.20 | -0.12 | -0.10 |
| Earnings Per Share Diluted | -0.08 | -0.23 | -0.01 | -0.20 | -0.12 | -0.10 |
| Weighted Average Shares Outstanding | 42.42 Million | 41.41 Million | 40.34 Million | 38.64 Million | 37.81 Million | 35.82 Million |
| Weighted Average Shares Outstanding (Diluted) | 42.42 Million | 41.41 Million | 40.34 Million | 38.64 Million | 37.81 Million | 36.45 Million |
| Gross Margin | 0.54 | 0.54 | 0.57 | 0.57 | 0.55 | 0.52 |
| EBIT Margin | 0.08 | -0.01 | 0.06 | 0.05 | 0.06 | 0.02 |
| Profit Margin | -0.03 | -0.08 | -0.00 | -0.08 | -0.04 | -0.03 |
| EBITDA | 9.49 Million | 944 Thousand | 11.31 Million | 5.49 Million | 7.5 Million | 5.36 Million |
| Earnings Before Tax Margin | 0.02 | -0.06 | 0.01 | -0.01 | 0.01 | 0.01 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 23.09 Million | 24.51 Million | 28.15 Million | 112.25 Million | 25.36 Million | 28.75 Million |
| Cost of Revenue | 11.21 Million | 11.07 Million | 13.21 Million | 51.38 Million | 10.63 Million | 12.08 Million |
| Gross Profit | 11.88 Million | 13.43 Million | 14.93 Million | 60.86 Million | 14.72 Million | 16.67 Million |
| Operating Expenses | 13.7 Million | 14.75 Million | 14.65 Million | 58.58 Million | 15.66 Million | 15.87 Million |
| Selling, General and Administrative Expenses | 11.08 Million | 11.86 Million | 11.5 Million | - | 11.53 Million | 11.53 Million |
| Research and Development Expenses | 2.62 Million | 2.88 Million | 3.15 Million | - | 2.76 Million | 2.95 Million |
| Other Expenses | -181 Thousand | -142 Thousand | -332 Thousand | -227 Thousand | 45 Thousand | -372 Thousand |
| Cost and Expenses | 24.91 Million | 25.82 Million | 27.87 Million | 109.96 Million | 26.29 Million | 27.96 Million |
| Operating Income | -1.82 Million | -1.31 Million | 282 Thousand | 2.28 Million | -933 Thousand | 796 Thousand |
| Interest Expense | 749 Thousand | 751 Thousand | 794 Thousand | 3.59 Million | 882 Thousand | 941 Thousand |
| Income Tax Expense | -353 Thousand | 210 Thousand | 715 Thousand | 859 Thousand | 677 Thousand | -1.11 Million |
| Earnings before Tax | -3.28 Million | -4.48 Million | -1.1 Million | -2.55 Million | -562 Thousand | -2.09 Million |
| Net Income | -2.92 Million | -4.69 Million | -1.81 Million | -3.41 Million | -1.23 Million | -980 Thousand |
| Earnings Per Share Basic | -0.07 | -0.11 | -0.04 | - | -0.03 | -0.02 |
| Earnings Per Share Diluted | -0.07 | -0.11 | -0.04 | - | -0.03 | -0.02 |
| Weighted Average Shares Outstanding | 43.48 Million | 43.4 Million | 42.71 Million | 42.42 Million | 42.68 Million | 42.35 Million |
| Weighted Average Shares Outstanding (Diluted) | 43.48 Million | 43.4 Million | 42.71 Million | 42.42 Million | 42.68 Million | 42.35 Million |
| Gross Margin | 0.51 | 0.55 | 0.53 | 0.54 | 0.58 | 0.58 |
| EBIT Margin | -0.00 | 0.02 | 0.07 | - | 0.02 | 0.06 |
| Profit Margin | -0.13 | -0.19 | -0.06 | -0.03 | -0.05 | -0.03 |
| EBITDA | -62 Thousand | 424 Thousand | 2.05 Million | - | 473 Thousand | 1.81 Million |
| Earnings Before Tax Margin | -0.08 | -0.05 | 0.01 | 0.02 | -0.04 | 0.03 |
BSBR
002150
JPNRF
PRN
7360
603421